The Manufacturers Life Insurance Company Buys Shares of 107,320 Envista Holdings Corporation $NVST

The Manufacturers Life Insurance Company bought a new position in shares of Envista Holdings Corporation (NYSE:NVST) in the 2nd quarter, Holdings Channel.com reports. The institutional investor bought 107,320 shares of the company’s stock, valued at approximately $2,828,000.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new stake in shares of Envista in the 2nd quarter valued at approximately $25,000. Caitong International Asset Management Co. Ltd grew its holdings in Envista by 16,711.1% during the third quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company’s stock valued at $31,000 after purchasing an additional 1,504 shares during the period. Allworth Financial LP increased its stake in Envista by 75.4% in the fourth quarter. Allworth Financial LP now owns 1,805 shares of the company’s stock valued at $39,000 after purchasing an additional 776 shares in the last quarter. UMB Bank n.a. increased its stake in Envista by 46.1% in the fourth quarter. UMB Bank n.a. now owns 2,017 shares of the company’s stock valued at $44,000 after purchasing an additional 636 shares in the last quarter. Finally, IFP Advisors Inc raised its holdings in Envista by 102.9% in the fourth quarter. IFP Advisors Inc now owns 2,112 shares of the company’s stock worth $46,000 after purchasing an additional 1,071 shares during the period.

Insider Activity

In related news, SVP Mischa Reis sold 8,000 shares of Envista stock in a transaction dated Thursday, August 20th. The stock was sold at an average price of $27.50, for a total value of $220,000.00. Following the sale, the senior vice president owned 27,321 shares of the company’s stock, valued at approximately $751,327.50. The trade was a 22.65% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.99% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the stock. Wall Street Zen raised shares of Envista from a “buy” rating to a “strong-buy” rating in a report on Saturday, August 22nd. Barclays decreased their target price on Envista from $34.00 to $32.00 and set an “overweight” rating for the company in a research note on Thursday, June 11th. Evercore reaffirmed an “outperform” rating and set a $33.00 price target on shares of Envista in a research report on Thursday, May 7th. Piper Sandler reiterated a “neutral” rating and set a $28.00 price objective (up from $26.00) on shares of Envista in a report on Thursday, August 6th. Finally, BMO Capital Markets initiated coverage on Envista in a research report on Wednesday, July 8th. They issued a “market perform” rating and a $27.00 price objective for the company. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and nine have given a Hold rating to the stock. According to MarketBeat, Envista has a consensus rating of “Moderate Buy” and a consensus target price of $29.31.

Envista Stock Down 1.8%

NVST stock opened at $26.66 on Wednesday. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.43 and a quick ratio of 2.07. The stock has a market capitalization of $4.28 billion, a P/E ratio of 45.97, a P/E/G ratio of 1.29 and a beta of 0.86. The business has a 50-day moving average of $27.18 and a 200-day moving average of $26.31. Envista Holdings Corporation has a fifty-two week low of $18.77 and a fifty-two week high of $30.42.

Envista (NYSE:NVST) last announced its earnings results on Wednesday, August 5th. The company reported $0.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.34 by $0.07. The business had revenue of $730.50 million for the quarter, compared to analyst estimates of $716.11 million. Envista had a return on equity of 7.88% and a net margin of 3.33%.Envista’s revenue for the quarter was up 7.1% compared to the same quarter last year. During the same quarter last year, the firm earned $0.26 EPS. Envista has set its FY 2026 guidance at 1.500-1.550 EPS. On average, sell-side analysts anticipate that Envista Holdings Corporation will post 1.53 earnings per share for the current fiscal year.

Envista Company Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.